Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
RaQualia Pharma, Returning to Profitability This Year
4579 RaQualia Pharma Inc. 【J-GAAP】
Earnings ReportRaQualia Pharma Inc. <4579> [TSE Growth] announced its financial results after the market closed on February 14th (15:45). The consolidated ordinary loss for the fiscal year ending December 2024 expanded to a loss of 361 million yen (compared to a loss of 293 million yen in the previous period). The result was better than the previously estimated deficit of loss of 476 million yen. In the fiscal year ending December 2025, the profit is expected to turn into a profit of 73 million yen.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary loss improved to a deficit of 130 million yen (compared to a loss of 257 million yen in the same period last year). The operating profit/loss margin drastically improved from -56.4% in the same period last year to -25.2%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 2,918 | 866 | 904 | 723 | 34.5 | 0 | Feb 14, 2023 | J-GAAP |
Dec, 2023 | 1,901 | -337 | -293 | -323 | -15.0 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 3,107 | -213 | -361 | -495 | -22.9 | 0 | Feb 14, 2025 | J-GAAP |
YoY | +63.4% | +36.8% | -23.2% | -53.3% | -52.7% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 3,135 | -234 | -476 | -584 | -26.7 | 0 | Dec 13, 2024 | J-GAAP |
Dec, 2024 Results | 3,107 | -213 | -361 | -495 | -22.9 | 0 | Feb 14, 2025 | J-GAAP |
Revision Rate | -0.9% | +9.0% | +24.2% | +15.2% | +14.5% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 1,411 | -154 | -277 | -323 | -15.0 | 0 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 1,901 | -337 | -293 | -323 | -15.0 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 3,107 | -213 | -361 | -495 | -22.9 | 0 | Feb 14, 2025 | J-GAAP |
Dec, 2025 Guidance | 3,888 | 118 | 73 | -71 | -2.9 | 0 | Feb 14, 2025 | J-GAAP |
YoY | +25.1% | - | - | +85.7% | +87.3% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 406 | -229 | -257 | -206 | -9.6 | -56.4 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 648 | 44 | -77 | -78 | -3.6 | 6.8 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 763 | -198 | -200 | -245 | -11.4 | -26.0 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 958 | 127 | 46 | -16 | -0.7 | 13.3 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 738 | -186 | -130 | -156 | -7.2 | -25.2 | Feb 14, 2025 | J-GAAP |
YoY | +81.8% | +18.8% | +49.4% | +24.3% | +24.5% |
Related Articles
Writeup, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3.5 times, Oct-Dec Ordinary Profit Increases by 2.3 times
TRADE WORKS, Returning to Profitability This Year
KIKUSUI CHEMICAL, Oct-Dec (3Q) Ordinary Profit Decreases by 46%
DENTSU, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, Returning to Profitability This Year
AMUSE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.6 times, Exceeds Full-Year Plan
TOYO DRILUBE, First Half Ordinary Profit Increases by 25%, Oct-Dec Ordinary Profit Increases by 20%
MANDARAKE, Oct-Dec (1Q) Ordinary Profit Decreases by 45%
Oriental Consultants, Oct-Dec (1Q) Ordinary Profit Increases by 7.3 times
EBARA Foods Industry, The Current Fiscal Year Ordinary Profit Revised Upward by 40%, Dividend Revised Upward by 5 yen
Naigai Tec, The Current Fiscal Year Ordinary Profit Revised Downward by 5%